We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-0.12%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$3.91B
AUM Growth
+$545M
Cap. Flow
+$210M
Cap. Flow %
5.36%
Top 10 Hldgs %
40.38%
Holding
2,228
New
603
Increased
482
Reduced
356
Closed
557

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$84.4M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$81.5M
3
VAL icon
Valaris
VAL
+$24.1M
4
CAI
CAI International, Inc.
CAI
+$12.6M
5
STMP
Stamps.com, Inc.
STMP
+$11M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$22.9M
2
PRAH
PRA Health Sciences, Inc.
PRAH
+$19.4M
3
PFPT
Proofpoint, Inc.
PFPT
+$19M
4
AAWW
Atlas Air Worldwide Holdings, Inc.
AAWW
+$16.1M
5
MXIM
Maxim Integrated Products
MXIM
+$15.5M

Sector Composition

Rank Sector Weight
1 Financials 9.4%
2 Technology 6.32%
3 Consumer Discretionary 5.14%
4 Industrials 4.27%
5 Communication Services 2.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PROCW
1576
DELISTED
Procaps Group, S.A. Warrants
PROCW
$13K ﹤0.01%
+11,946
New +$12.9K
OCAXW
1577
DELISTED
OCA Acquisition Corp. Warrant
OCAXW
$13K ﹤0.01%
23,767
+5,200
+28% +$3.04K
FOXO.WS
1578
DELISTED
FOXO Technologies Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FOXO.WS
$13K ﹤0.01%
20,040
– –
SWETW
1579
DELISTED
Athlon Acquisition Corp. Warrant
SWETW
$13K ﹤0.01%
19,212
+324
+2% +$242
GLAQW
1580
DELISTED
Globis Acquisition Corp. Warrant
GLAQW
$13K ﹤0.01%
20,253
– –
SCLXW icon
1581
Scilex Holding Co Warrant
SCLXW
$12K ﹤0.01%
23,225
+5,000
+27% +$2.89K
MMVWW
1582
DELISTED
MultiMetaVerse Holdings Limited Warrant
MMVWW
$12K ﹤0.01%
25,750
+750
+3% +$395
PGRWW
1583
DELISTED
Progress Acquisition Corp. Warrant
PGRWW
$12K ﹤0.01%
21,106
+6,101
+41% +$3.91K
ALTIW
1584
DELISTED
AlTi Global Inc Warrant
ALTIW
$12K ﹤0.01%
11,666
+1,666
+17% +$1.36K
AEACW
1585
DELISTED
Authentic Equity Acquisition Corp. Warrant
AEACW
$12K ﹤0.01%
17,367
– –
RXRAW
1586
DELISTED
RXR Acquisition Corp. Warrants to purchase Class A common stock
RXRAW
$12K ﹤0.01%
16,140
– –
SLCRW
1587
DELISTED
Silver Crest Acquisition Corporation Warrant
SLCRW
$12K ﹤0.01%
17,621
+6,698
+61% +$4.78K
REVBW icon
1588
Revelation Biosciences Warrant
REVBW
$11K ﹤0.01%
17,755
+722
+4% +$438
PDYNW icon
1589
Palladyne AI Corp Warrants
PDYNW
$162K
$11K ﹤0.01%
14,524
– –
TWLVW
1590
DELISTED
Twelve Seas Investment Company II Warrant
TWLVW
$11K ﹤0.01%
17,289
– –
ACBAW
1591
DELISTED
Ace Global Business Acquisition Ltd Warrant
ACBAW
$11K ﹤0.01%
22,456
+3,461
+18% +$1.92K
UPH.WS
1592
DELISTED
UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share
UPH.WS
$11K ﹤0.01%
+23,059
New +$14.7K
IBER.WS
1593
DELISTED
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
$11K ﹤0.01%
18,101
+400
+2% +$269
BIOTW
1594
DELISTED
Biotech Acquisition Company Warrant
BIOTW
$11K ﹤0.01%
16,004
– –
OSTRW
1595
DELISTED
Oyster Enterprises Acquisition Corp. Warrant
OSTRW
$11K ﹤0.01%
19,469
+350
+2% +$214
WARR.WS
1596
DELISTED
Warrior Technologies Acquisition Company Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
WARR.WS
$11K ﹤0.01%
20,376
+761
+4% +$513
KWAC.WS
1597
DELISTED
Kingswood Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common
KWAC.WS
$11K ﹤0.01%
23,337
+5,006
+27% +$2.93K
RMCOW icon
1598
Royalty Management Holding Warrant
RMCOW
$1.83M
$10K ﹤0.01%
18,484
– –
FSSIW
1599
DELISTED
Fortistar Sustainable Solutions Corp. Warrant
FSSIW
$10K ﹤0.01%
+13,951
New +$12.3K
EQHA.WS
1600
DELISTED
EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
EQHA.WS
$10K ﹤0.01%
17,270
+650
+4% +$412
62 63
64
65 66

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Prelude Capital Management held 2,228 positions worth $3.91B, up 16% from $3.36B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Prelude Capital Management deployed $210M of net new capital in Q3 2021, opening 603 new positions and adding to 482 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 208,151 shares worth $82.1M.

By sector, the portfolio is most concentrated in Financials at 9.4% of assets, up from 8.9% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Frontier Communications, an estimated $8.65M trimmed.

  • Prelude Capital Management's largest Q3 2021 buy was Vanguard S&P 500 ETF: 208,151 shares worth $82.1M.
  • Prelude Capital Management added most to Valaris in Q3 2021, an estimated $24.1M increase.
  • Prelude Capital Management's biggest Q3 2021 reduction was Frontier Communications, cutting an estimated $8.65M.
  • Prelude Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $22.9M.
  • Prelude Capital Management's ten largest holdings make up 40% of its $3.91B portfolio in Q3 2021.
  • Prelude Capital Management opened 603 new positions and closed 557 in Q3 2021.
  • Prelude Capital Management's portfolio value rose 16% quarter-over-quarter to $3.91B.

Based on Prelude Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.